FMC Corp  

(Public, NYSE:FMC)   Watch this stock  
Find more results for FMC CORPORATION�
-0.48 (-0.62%)
Real-time:   12:37PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 76.08 - 77.18
52 week 55.71 - 83.94
Open 77.07
Vol / Avg. 284,247.00/1.06M
Mkt cap 10.17B
P/E 22.85
Div/yield 0.15/0.78
EPS 3.35
Shares 133.07M
Beta 1.16
Inst. own 94%
May 7, 2014
Q1 2014 FMC Corporation Earnings Conference Call - 11:00AM EDT - Add to calendar
May 6, 2014
Q1 2014 FMC Corporation Earnings Release - 4:00PM EDT - Add to calendar
Apr 29, 2014
FMC Corporation Annual Shareholder Meeting - 2:00PM EDT - Add to calendar
Mar 10, 2014
FMC Corporation Announces Separation into Two Independent Public Companies Conference Call - Webcast
Feb 26, 2014
FMC Corporation at Bank of America Merrill Lynch Global Agriculture Conference - Webcast
Feb 6, 2014
Q4 2013 FMC Corporation Earnings Conference Call - Webcast
Feb 5, 2014
Q4 2013 FMC Corporation Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 11.75% 12.06%
Operating margin 15.88% 17.01%
EBITD margin - 21.53%
Return on average assets 10.49% 9.73%
Return on average equity 35.99% 30.11%
Employees 5,600 -
CDP Score - -


1735 Market Street
United States - Map
+1-215-2996000 (Phone)
+1-215-2995998 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


FMC Corporation (FMC) is a diversified chemical company. The Company operates in three business segments: Agricultural Products, Specialty Chemicals and Industrial Chemicals. Its Agricultural Products segment develops, markets and sells all three classes of crop protection chemicals, such as insecticides, herbicides, and fungicides, with particular strength in insecticides and herbicides. Specialty Chemicals consists of its BioPolymer and lithium businesses and focuses on food ingredients that are used to enhance texture, color, structure and physical stability; pharmaceutical additives for binding, encapsulation and disintegrate applications, ultrapure biopolymers for medical devices, and lithium for energy storage, specialty polymers and pharmaceutical synthesis. Its Industrial Chemicals segment manufactures a range of inorganic materials. In March 2014, the Company announced that it has completed the sale of its Peroxygens business to affiliates of One Equity Partners.

Officers and directors

Pierre R. Brondeau Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Paul W. Graves Chief Financial Officer, Executive Vice President
Age: 41
Bio & Compensation  - Reuters
Mark A. Douglas President - Agricultural Products Group
Age: 50
Bio & Compensation  - Reuters
Edward T. Flynn President - Industrial Chemicals Group
Age: 54
Bio & Compensation  - Reuters
Andrea E. Utecht Executive Vice President, General Counsel, Secretary
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Thomas C. Deas Jr. Vice President, Treasurer
Age: 62
Bio & Compensation  - Reuters
Andrew Sandifer Vice President - Strategic Development, Investor Relations Officer
Bio & Compensation  - Reuters
Nicholas L. Pfeiffer Corporate Controller
Age: 41
Bio & Compensation  - Reuters
Edward J. Mooney Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
K'Lynne Johnson Director
Age: 43
Bio & Compensation  - Reuters